메뉴 건너뛰기




Volumn 66, Issue 2, 2015, Pages 193-195

Metformin Use in Type 2 Diabetes Mellitus with CKD: Is It Time to Liberalize Dosing Recommendations?

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LACTIC ACID; METFORMIN; ANTIDIABETIC AGENT;

EID: 84937966491     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.04.001     Document Type: Editorial
Times cited : (11)

References (17)
  • 1
    • 84873733300 scopus 로고    scopus 로고
    • Metformin: An old but still the best treatment for type 2 diabetes
    • L.B. Rojas, and M.B. Gomes Metformin: an old but still the best treatment for type 2 diabetes Diabetol Metab Syndr 5 1 2013 6
    • (2013) Diabetol Metab Syndr , vol.5 , Issue.1 , pp. 6
    • Rojas, L.B.1    Gomes, M.B.2
  • 2
    • 84864144168 scopus 로고    scopus 로고
    • Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: A cohort study from the Swedish National Diabetes Register
    • N. Ekstrom, L. Schioler, A.M. Svensson, and et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register BMJ Open 2 4 2012
    • (2012) BMJ Open , vol.2 , Issue.4
    • Ekstrom, N.1    Schioler, L.2    Svensson, A.M.3
  • 3
    • 78851470539 scopus 로고    scopus 로고
    • Effect of metformin on cardiovascular events and mortality: A meta-analysis of randomized clinical trials
    • C. Lamanna, M. Monami, N. Marchionni, and E. Mannucci Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials Diabetes Obes Metab 13 3 2011 221 228
    • (2011) Diabetes Obes Metab , vol.13 , Issue.3 , pp. 221-228
    • Lamanna, C.1    Monami, M.2    Marchionni, N.3    Mannucci, E.4
  • 5
    • 84937988602 scopus 로고    scopus 로고
    • Centers for Disease Control. Diabetes: successes and opportunities for population-based prevention and control. At A Glance 2011. Accessed February 21, 2015
    • Centers for Disease Control. Diabetes: successes and opportunities for population-based prevention and control. At A Glance 2011. http://www.cdc.gov/chronicdisease/resources/publications/AAG/ddt.htm. Accessed February 21, 2015.
  • 7
    • 84920025605 scopus 로고    scopus 로고
    • Metformin in patients with type 2 diabetes and kidney disease: A systematic review
    • S.E. Inzucchi, K.J. Lipska, H. Mayo, C.J. Bailey, and D.K. McGuire Metformin in patients with type 2 diabetes and kidney disease: a systematic review JAMA 312 24 2014 2668 2675
    • (2014) JAMA , vol.312 , Issue.24 , pp. 2668-2675
    • Inzucchi, S.E.1    Lipska, K.J.2    Mayo, H.3    Bailey, C.J.4    McGuire, D.K.5
  • 8
    • 84889038435 scopus 로고    scopus 로고
    • Unleash metformin: Reconsideration of the contraindication in patients with renal impairment
    • W.R. Lu, J. Defilippi, and A. Braun Unleash metformin: reconsideration of the contraindication in patients with renal impairment Ann Pharmacother 47 11 2013 1488 1497
    • (2013) Ann Pharmacother , vol.47 , Issue.11 , pp. 1488-1497
    • Lu, W.R.1    Defilippi, J.2    Braun, A.3
  • 9
    • 77950868733 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
    • S.R. Salpeter, E. Greyber, G.A. Pasternak, and E.E. Salpeter Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus Cochrane Database Syst Rev 14 4 2010 CD002967
    • (2010) Cochrane Database Syst Rev , vol.14 , Issue.4 , pp. CD002967
    • Salpeter, S.R.1    Greyber, E.2    Pasternak, G.A.3    Salpeter, E.E.4
  • 10
    • 59249083934 scopus 로고    scopus 로고
    • Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis
    • M. Bodmer, C. Meier, S. Krahenbuhl, S.S. Jick, and C.R. Meier Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis Diabetes Care 31 11 2008 2086 2091
    • (2008) Diabetes Care , vol.31 , Issue.11 , pp. 2086-2091
    • Bodmer, M.1    Meier, C.2    Krahenbuhl, S.3    Jick, S.S.4    Meier, C.R.5
  • 11
    • 84904999202 scopus 로고    scopus 로고
    • Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: A population-based cohort study
    • W.L. Eppenga, A. Lalmohamed, A.F. Geerts, and et al. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study Diabetes Care 37 8 2014 2218 2224
    • (2014) Diabetes Care , vol.37 , Issue.8 , pp. 2218-2224
    • Eppenga, W.L.1    Lalmohamed, A.2    Geerts, A.F.3
  • 12
    • 84905020679 scopus 로고    scopus 로고
    • Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: A retrospective cohort study
    • F.F. Richy, M. Sabido-Espin, S. Guedes, F.A. Corvino, and U. Gottwald-Hostalek Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study Diabetes Care 37 8 2014 2291 2295
    • (2014) Diabetes Care , vol.37 , Issue.8 , pp. 2291-2295
    • Richy, F.F.1    Sabido-Espin, M.2    Guedes, S.3    Corvino, F.A.4    Gottwald-Hostalek, U.5
  • 13
    • 84876068053 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods
    • G. Booth, and A.Y. Cheng Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods Can J Diabetes 37 suppl 1 2013 S61 S68
    • (2013) Can J Diabetes , vol.37 , pp. S61-S68
    • Booth, G.1    Cheng, A.Y.2
  • 14
    • 84937971391 scopus 로고    scopus 로고
    • The Royal Australian College of General Practitioners Accessed February 22, 2015
    • The Royal Australian College of General Practitioners. General practice management of type 2 diabetes. 2014-2015. http://www.racgp.org.au/your-practice/guidelines/diabetes/. Accessed February 22, 2015.
    • General Practice Management of Type 2 Diabetes. 2014-2015
  • 15
    • 75349095555 scopus 로고    scopus 로고
    • Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin
    • S.K. Goergen, G. Rumbold, G. Compton, and C. Harris Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin Radiology 254 1 2010 261 269
    • (2010) Radiology , vol.254 , Issue.1 , pp. 261-269
    • Goergen, S.K.1    Rumbold, G.2    Compton, G.3    Harris, C.4
  • 17
    • 84922253642 scopus 로고    scopus 로고
    • Metformin and other antidiabetic agents in renal failure patients
    • J.D. Lalau, P. Arnouts, A. Sharif, and M.E. De Broe Metformin and other antidiabetic agents in renal failure patients Kidney Int 87 2 2015 308 322
    • (2015) Kidney Int , vol.87 , Issue.2 , pp. 308-322
    • Lalau, J.D.1    Arnouts, P.2    Sharif, A.3    De Broe, M.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.